The anti-tumor potential of sinomenine: a narrative review.

Publication Year: 2023

DOI:
10.21037/tcr-23-267

PMCID:
PMC10583013

PMID:
37859743

Journal Information

Full Title: Transl Cancer Res

Abbreviation: Transl Cancer Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-267/coif). The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported by National Natural Science Foundation of China ( Grant No. 82060477 ); Natural Science Foundation of Jiangxi Province ( Grant No. 20202BAB206054 ); Science and Technology Plan of Jiangxi Provincial Health Commission in 2021 ( No. 202120072 ); Nanchang Advantage science and technology Innovation team construction Plan project [ Hongke Zi (2019) No. 228-15 ]; Nanchang high-level scientific and technological innovation talents “Double Hundred Plan “project [ Hongke Zi (2021) No. 156-29 ]; General project of Traditional Chinese Medicine Science and Technology Plan of Jiangxi Province in 2021 ( No. 2021B666 ); and Jiangxi Province Graduate Students Innovation Special Fund project in 2022 ( No. YC2022-B069 )."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025